Lorenz R Rhomberg researcher (ORCID 0000-0002-0765-626X)
Rhomberg, Lorenz
VIAF ID: 56449712 ( Personal )
Permalink: http://viaf.org/viaf/56449712
Preferred Forms
-
100 0 _
‡a
Lorenz R Rhomberg
‡c
researcher (ORCID 0000-0002-0765-626X)
-
100 1 _
‡a
Rhomberg, Lorenz
-
100 1 _ ‡a Rhomberg, Lorenz
-
100 1 _
‡a
Rhomberg, Lorenz
-
100 1 _ ‡a Rhomberg, Lorenz
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| The a posteriori probability of a kidney cancer cluster attributed to trichloroethylene exposure |
|
| Absolute risk or relative risk? A study of intraspecies and interspecies extrapolation of chemical-induced cancer risk |
|
| Advancements in Life Cycle Human Exposure and Toxicity Characterization |
|
| Analytical framework for assessing risks |
|
| Assessing human health response in life cycle assessment using ED10s and DALYs: part 2--Noncancer effects. |
|
| Causes of Life History Differences between the Morphs of Pemphigus populitransversus |
|
| CERHR conclusions would have been strengthened by a more explicit weight-of-evidence analysis. |
|
| Comment on "Chronic disease and early exposure to air-borne mixtures. 2. Exposure assessment" |
|
| Comment on "Residential and biological exposure assessment of chemicals from a wood treatment plant" by James Dahlgren et al. [Chemosphere 67(9) (2007) S279-S285] |
|
| A comprehensive evaluation of the potential health risks associated with occupational and environmental exposure to styrene |
|
| Contrasting directions and directives on hazard identification for formaldehyde carcinogenicity |
|
| Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012. |
|
| A critique of the European Commission document, "State of the Art Assessment of Endocrine Disrupters". |
|
| Effects of MTBE on the reported incidence of Leydig cell tumors in Sprague-Dawley rats: range of possible Poly-3 results. |
|
| Evaluation of Acute Nonlymphocytic Leukemia and Its Subtypes With Updated Benzene Exposure and Mortality Estimates: A Lifetable Analysis of the Pliofilm Cohort. |
|
| Evaluation of the causal framework used for setting national ambient air quality standards. |
|
| Hypothesis-based weight-of-evidence evaluation of the human carcinogenicity of toluene diisocyanate. |
|
| Improving weight of evidence approaches to chemical evaluations |
|
| Incorporating Low-dose Epidemiology Data in a Chlorpyrifos Risk Assessment |
|
| Incorporating ToxCast™ data into naphthalene human health risk assessment |
|
| Is exposure to formaldehyde in air causally associated with leukemia?--A hypothesis-based weight-of-evidence analysis |
|
| Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection. |
|
| Letter to the editor re: Guyton et al. (2018), 'Application of the key characteristics of carcinogens in cancer hazard identification' |
|
| Linear low-dose extrapolation for noncancer responses is not generally appropriate. |
|
| Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? |
|
| A margin-of-exposure approach to assessment of noncancer risks of dioxins based on human exposure and response data |
|
| Measurement error in environmental epidemiology and the shape of exposure-response curves. |
|
| Mechanisms of action for arsenic in cardiovascular toxicity and implications for risk assessment. |
|
| Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study. |
|
| THE NATURE OF GENETIC VARIATION FOR SPECIES FORMATION |
|
| Practical Risk Assessment and Management Issues Arising were we to Adopt Low-Dose Linearity for all Endpoints |
|
| Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data |
|
| Quantitative cancer risk assessment for occupational exposures to asphalt fumes during built-up roofing asphalt (BURA) operations. |
|
| Recommendations for the conduct of systematic reviews in toxicology and environmental health research (COSTER) |
|
| Seeking optimal design for animal bioassay studies |
|
| Strategies to protect the health of deployed U.S. forces, c2000: |
|
| Strengthening the foundation of next generation risk assessment. |
|
| A survey of frameworks for best practices in weight-of-evidence analyses. |
|
| Systematic comparison of study quality criteria. |
|
| Toxicity testing in the 21st century: how will it affect risk assessment? |
|
| Toxicological evaluation of carcinogenicity of the pyrethroid imiprothrin in rats and mice |
|
| Uncertainty factor conundrums: what lessons should we draw? |
|
| Weighing evidence and assessing uncertainties |
|
| Weight-of-evidence analysis of human exposures to dioxins and dioxin-like compounds and associations with thyroid hormone levels during early development. |
|
| The Weight of Evidence Does Not Support the Listing of Styrene as "Reasonably Anticipated to be a Human Carcinogen" in NTP's Twelfth Report on Carcinogens |
|
| Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. |
|
